Exane Derivatives’s Tricida, Inc. Common Stock TCDA Stock Holding History

Exane Derivatives’s Portfolio TCDA Stock Details TCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,075	Closed	-$46K	–	875
2020 Q3	$46K	Buy	5,075 +1,695	+50%	+$24.8K	0.01%	379
2020 Q2	$92.9K	Hold	3,380	–	–	0.02%	304
2020 Q1	$74.4K	Buy	+3,380	New	+$109K	0.02%	320

Other funds holding TCDA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Exane Derivatives's TCDA Position: Q4 2020 in Review

Exane Derivatives sold out of Tricida, Inc. Common Stock (TCDA) in Q4 2020, closing a stake of 5,075 shares — an estimated $46K sold.

Exane Derivatives first reported a position in TCDA in Q1 2020 and held it in 3 quarters. The position peaked at $92.9K in Q2 2020. 113 funds tracked by Wall St. Rank hold TCDA as of Q4 2020.

Exane Derivatives reported no remaining Tricida, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 5,075 Tricida, Inc. Common Stock shares in Q4 2020, an estimated $46K.
Exane Derivatives first reported a position in Tricida, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
Exane Derivatives's Tricida, Inc. Common Stock position peaked at $92.9K in Q2 2020.
113 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.